Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/S%26P+Announces+Changes+to+US+Indices%3A+%28NCI%29+for+%28GXDX%29+in+SmallCap+600%2C+%28NOG%29+for+NCI+in+MidCap+400/6319097.html for the full story.
Clinical Data, Inc. (NASDAQ:CLDA) surged by 67.47% to close at $25.17 with overall traded volume of 15.60 million shares in the last trading day. Its outstanding share stood at 29.96 million. Its total market capitalization stood at $754.09...
Chase Coleman’s Tiger Global is raising $1.25 billion for its sixth private-equity fund. $80 million has already been used to enlarge the firm's stake in Facebook.
John Paulson made $1 billion on Citi.
Steve Cohen made ~$7 million on...
NEW YORK (TheStreet) -- Clinical Data was the biggest gainer among small-caps Monday afternoon, its shares soaring 55% to $23.30, after U.S. regulators approved its major depressive disorder treatment Viibryd. The biotech company said the drug...
Of course Cohen made out like a bandit in today's sale of Genoptix to Novartis.
Remember SAC Capital's epic Dendreon trade? The firm made between $65 million and $100 million when the FDA approved a new prostate cancer drug.
This time, SAC...
Shares of Genoptix Inc. rallied 26% in premarket trading Monday on news that the laboratory services provider has agreed to be bought by Novartis AG for $25 in cash, or around $470 million. The company said the enterprise value of the deal will...
Mergers and acquisitions news is usually a positive catalyst for stocks and that theme is playing out today as the Medical Labs and Diagnostic Services Stocks Index is up 1.7% on news that Genoptix (GXDX) has put itself up for sale.
Shares of...
Oops! Unable to complete your request. Please refresh your browser.